Background Since the start of the new Coronavirus (COVID-19) outbreak in December 2019,
pharmacists worldwide are playing a key role adopting innovative strategies to minimize the …

Background Multiple reviews have evaluated the impact of pharmacist-delivered patient
care on health-related outcomes. However, it is unclear which of the pharmacist-delivered …

What is known and objectives Most antineoplastic drugs are highly toxic and have low
therapeutic indexes, which can result in drug‐related problems. In this context, pharmacist …

Abstract Background Pharmaceutical Care Network Europe (PCNE) proposed a definition
and classification system (type 1, 2a, 2b, 3) for medication review in 2016. However, to date …

Multiple terms and definitions exist to describe specific aspects of pharmacy practice and
service provision. This commentary explores the reasons for different interpretations of …

Objective: To evaluate the impact of pharmaceutical care (PC) interventions on health-
related quality of life (HRQoL) and determine sensitivity of HRQoL measures to PC services …

Pharmacists are essential members of the healthcare team. The emergence of the novel
coronavirus disease 2019 (COVID-19) pandemic has led pharmacists to undertake …

The United States (US) has a complex healthcare system with a mix of public, private,
nonprofit, and for-profit insurers, healthcare institutions and organizations, and providers …

People living with human immunodeficiency virus/acquired immunodeficiency syndrome
(HIV/AIDS; PLWHA) frequently encounter antiretroviral (ARV) therapy-related problems …

Rationale, aims and objectives This study aimed to evaluate the effect of a pharmacist–
physician collaborative care model on clinical outcomes in patients with uncontrolled type 2 …